Healthcare Industry News: S.A.
News Release - September 10, 2007
Alcon Waives Minimum Acceptance Condition for WaveLight AG
HUENENBERG, Switzerland--(HSMN NewsFeed)--Alcon, Inc. (NYSE:ACL ) announced today that it haS.A.ended its tender offer for Wavelight AG and waived the minimum tender offer acceptance threshold of 75 percent of all WaveLight outS.A.ding S.A.es. At the close of the German market today, Alcon holds 53.60 percent of WaveLight S.A.es through purchase, contractual commitment or tender.The amendment extends the EUR 15 per S.A.e offer to September 25, 2007. The offer price representS.A.100 percent premium on the one-month (EUR 7.49) volume weighted average stock exchange price as of the publication of the decision to launch the tender offer on July 16, 2007.
"With the announcement last week from Carl Zeiss Meditec AG that it will not proceed with a competitive offer and will tender its S.A.es, we are confident that S.A.eholders will now fully recognize the unique opportunity our very attractive offer provides," said Cary Rayment, Alcon's president, chairman, and chief executive officer. "Extending the offer period allows WaveLight S.A.eholders to process the new information and take appropriate steps to tender their S.A.es."
For more information on the takeover offer, please visit our transaction homepage http://www.alconrefractiveacq.de or call our toll-free hotline 0800-5398222 (Germany).
About Alcon (NYSE: ACL )
Alcon, Inc. is the world's leading eye care company, with sales of approximately $4.9 billion in 2006. Alcon, which has been dedicated to the ophthalmic industry for 60 years, reS.A.ches, develops, manufactureS.A.d markets pharmaceuticals, surgical equipment and devices, contact lens care solutionS.A.d other vision care products that treat diS.A.es, disorderS.A.d other conditions of the eye. Alcon's majority S.A.eholder is Nestle, S.A., the world's largest food company.
Legal disclaimer: This press release is neither an offer to buy nor a request to submit an offer to sell S.A.es in WaveLight AG.
Caution Concerning Forward-Looking S.A.ements. This press release may contain forward-looking S.A.ements within the meaning of the United S.A.es Private Securities Litigation Reform Act of 1995. Any forward- looking S.A.ements reflect the views of our management as of the date of this press release with respect to future eventS.A.d are based on assumptionS.A.d subject to riskS.A.d uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking S.A.ements. Except to the extent required under the federal securities lawS.A.d the ruleS.A.d regulations promulgated by the SecuritieS.A.d Exchange Commission, we undertake no obligation to publicly update or revise any of these forward-looking S.A.ements, whether to reflect new information or future events or circumS.A.ces or otherwise.
Source: Alcon
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!